Status:
RECRUITING
Angelman Syndrome Natural History Study
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
University of California, San Diego
Angelman Syndrome Biomarker & Outcome Measure Consortium (A-BOM)
Conditions:
Angelman Syndrome
Eligibility:
All Genders
Brief Summary
The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to...
Detailed Description
The overall goal is to increase our understanding of the long-term natural history of Angelman syndrome and obtain Angelman-specific norms for outcome measures that can be used in clinical trials, ult...
Eligibility Criteria
Inclusion
- Molecular diagnosis of Angelman syndrome
Exclusion
- Presence of another condition, unrelated to Angelman syndrome, that affects neurodevelopment
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2031
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04507997
Start Date
August 1 2018
End Date
April 1 2031
Last Update
April 3 2025
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Guerin Children's
Los Angeles, California, United States, 90048
2
Rady Children's Hospital, San Diego
San Diego, California, United States, 92123
3
Children's Hospital Colorado, Anschutz Medical Campus
Aurora, Colorado, United States, 80045
4
Emory University School of Medicine
Atlanta, Georgia, United States, 30322